He describes how sentiment and the M&A environment have been improving, as well as some areas of the financing market. However, he cautions that it is very difficult to get early-stage development funded and that companies need to be creative to get phase 1 studies done.
View all episodes
By BiotechTV
4.3
66 ratings
He describes how sentiment and the M&A environment have been improving, as well as some areas of the financing market. However, he cautions that it is very difficult to get early-stage development funded and that companies need to be creative to get phase 1 studies done.
3,223 Listeners
1,902 Listeners
123 Listeners
324 Listeners
61 Listeners
9,960 Listeners
86 Listeners
34 Listeners
353 Listeners
19 Listeners
60 Listeners
514 Listeners
41 Listeners
0 Listeners
4 Listeners
2 Listeners
6 Listeners
46 Listeners